CEO Tadeu Marroco frames the restructuring as a necessary evolution for a business struggling with stagnant growth. While the company promises support for those displaced by the transition, the urgency of the cuts underscores the pressure to protect margins. The savings are projected to materialize fully by 2028, providing the capital required to chase the surging market for nicotine alternatives.
BAT is currently pouring resources into products like Vuse vapes and Velo nicotine pouches to replace shrinking tobacco revenue. Despite this focus, the company remains trapped in a difficult environment. Aggressive competition from Philip Morris International and a thicket of regulatory hurdles in the United States have consistently blunted BAT’s momentum, making this radical headcount reduction a desperate attempt to regain financial footing.





Comments (0)
No comments yet. Be the first!